These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7843877)

  • 1. Reflections on the cost consequences of the new gene technology for health policy.
    Rosenau PV
    Int J Technol Assess Health Care; 1994; 10(4):546-61. PubMed ID: 7843877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, transfer, and diffusion of technologies for the detection of genetic disorders. Policy implications.
    Holtzman NA
    Int J Technol Assess Health Care; 1994; 10(4):562-72. PubMed ID: 7843878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues in genetic therapy.
    Penticuff J
    J Obstet Gynecol Neonatal Nurs; 1994; 23(6):498-501. PubMed ID: 7965255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diagnosis and treatment. Ethical considerations.
    Fost N
    Am J Dis Child; 1993 Nov; 147(11):1190-5. PubMed ID: 8237913
    [No Abstract]   [Full Text] [Related]  

  • 5. The genomics gamble.
    Cohen J
    Science; 1997 Feb; 275(5301):767-72. PubMed ID: 9036536
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic medicine. Powerful opportunities for good and greed.
    Dalzell MD
    Manag Care; 2001 May; 10(5):22-3, 27-8, 33-7. PubMed ID: 11392726
    [No Abstract]   [Full Text] [Related]  

  • 7. Coverage of genetic technologies under national health reform.
    Mehlman MJ; Botkin JR; Scarrow A; Woodhall A; Kass J; Siebenschuh E
    Am J Hum Genet; 1994 Nov; 55(5):1054-60. PubMed ID: 7977343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing genetic technologies. Two ethical issues.
    Murray TH
    Int J Technol Assess Health Care; 1994; 10(4):573-82. PubMed ID: 7843879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preimplantation genetics: a case for prospective action.
    Pergament E; Bonnicksen A
    Am J Med Genet; 1994 Aug; 52(2):151-7. PubMed ID: 7802000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic diagnosis: a first step toward genetic health care.
    Caskey CT
    Science; 1993 Oct; 262(5130):48-9. PubMed ID: 8211129
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary care and the human genome project. Into the breach.
    Doukas DJ
    Arch Fam Med; 1993 Nov; 2(11):1179-83. PubMed ID: 8124493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The commercial development of gene therapy in Europe and the USA.
    Martin PA; Thomas SM
    Hum Gene Ther; 1998 Jan; 9(1):87-114. PubMed ID: 9458246
    [No Abstract]   [Full Text] [Related]  

  • 13. The commercialization of human genetics: profits and problems.
    Caulfield T
    Mol Med Today; 1998 Apr; 4(4):148-50. PubMed ID: 9572055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations of the European society of human genetics on genetic testing for common disorders.
    Field A; Baxter K; Terry SF
    Genet Test Mol Biomarkers; 2011 May; 15(5):291-2. PubMed ID: 21561286
    [No Abstract]   [Full Text] [Related]  

  • 15. Shaping priorities in genetic medicine.
    Boyle PJ
    Hastings Cent Rep; 1995; 25(3 Suppl):S2-8. PubMed ID: 11654187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living with HUGO.
    McNamee D
    Lancet; 1995 Aug; 346(8973):497. PubMed ID: 7637489
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene enhancements' thorny ethical traits.
    Weiss R
    Washington Post; 1997 Oct; ():A1, A18-19. PubMed ID: 11647258
    [No Abstract]   [Full Text] [Related]  

  • 18. A primer on economic evaluations related to expansion of newborn screening for genetic and metabolic disorders.
    Hubbard HB
    J Obstet Gynecol Neonatal Nurs; 2006; 35(6):692-9. PubMed ID: 17105633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogenetics policy: three kinds of models.
    Nordgren A
    Community Genet; 1998; 1(2):61-70. PubMed ID: 11657630
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives. Will genome science shift clinical, insurance paradigms?
    Clemmitt M
    Med Health; 2000 Sep; 54(37):suppl 1-4. PubMed ID: 11184793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.